Related Experiment Video

Updated: Jul 3, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

Ups and downs: the STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling

Gabriella Regis1, Sara Pensa, Daniela Boselli

  • 1Molecular Biotechnology Center, University of Turin, via Nizza 52, 10126 Turin, Italy. gabriella.regis@unito.it

Seminars in Cell & Developmental Biology
|July 16, 2008
PubMed

Insights

Signal transducer and activator of transcription (STAT) proteins STAT1 and STAT3 play opposing roles in immune responses and cell fate. Dysregulation of STAT1/3 balance offers potential therapeutic strategies, especially in cancer treatment.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cell Biology

Background:

  • Signal transducer and activator of transcription (STAT) proteins are key mediators of cytokine and growth factor signaling.
  • STAT1 and STAT3 have distinct and often opposing roles in regulating inflammation, cell proliferation, survival, and immune responses.

Purpose of the Study:

  • To review the canonical and non-canonical functions of STAT1 and STAT3.
  • To explore the therapeutic potential of modulating STAT1/3 pathways in various clinical settings, with a focus on cancer.

Main Methods:

  • Literature review of STAT1 and STAT3 signaling pathways.
  • Analysis of the reciprocal regulation between STAT1 and STAT3 activation.
  • Discussion of the implications of STAT1/3 dysregulation in disease.

Main Results:

  • STAT3 generally promotes anti-inflammatory effects, cell survival, and immune tolerance.
  • STAT1 typically inhibits proliferation and enhances innate and adaptive immunity.
  • Reciprocal regulation of STAT1 and STAT3 suggests a delicate balance in cellular signaling.

Conclusions:

  • Perturbations in STAT1/3 expression or activation levels can shift cellular responses (e.g., from proliferative to apoptotic).
  • Targeting STAT1/3 pathways represents a promising therapeutic strategy for cancer and other diseases.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...